Here are relevant reports on : trust-and-safety-software-market
-
Zero Trust Architecture Market by Solutions (IAM, Microsegmentation, ZTNA, Continuous Monitoring, Least Privilege Access), by Organization Size (SMB, Large Enterprises), by Deployment Mode (On-premise, Cloud), Vertical, and Region - Forecast to 2029
the global zero trust architecture market size is projected to reach USD 38.5 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 17.3% during the forecast period. Palo Alto Networks (US), VMware (US), Zscaler (US), Akamai (US), Microsoft (US), Cisco (US), IBM (US), Citrix (US), Check Point (US), Trellix (US), Forcepoint (US), CrowdStrike (US), Cloudflare (US), Fortinet (US), Google (US), Netskope (US), Perimeter 81 (US), Twingate (US), Appgate (US), Zero Networks (Israel), Versa Networks (US), Axis Security (US), Ivanti (US), NordLayer (US), and GoodAccess (Czech Republic) are the key players and other players in the zero-trust architecture market.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Medical Radiation Detection, Monitoring & Safety Market by Product (Personal Dosimeters (Passive Dosimeters)), Safety (Full Body, Face Protection, Hand Safety), Detector (Gas-Filled, Scintillators, Solid-State), End User - Global Forecast to 2029
The global medical radiation detection, monitoring & safety market, valued at US$1.17 billion in 2023, stood at US$1.26 billion in 2024 and is projected to advance at a resilient CAGR of 8.5% from 2024 to 2029, culminating in a forecasted valuation of US$1.89 billion by the end of the period. Growth in the Asia-Pacific market can be attributed to economic growth in the countries of this region, large population base, and rising incidence of cancer
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Top 10 Food Safety Testing and Technologies Trends Market (Food Safety, GM Food Safety, Food Pathogen, Meat Speciation, Food Authenticity, Pesticide Residue, Mycotoxin, Allergen, Water, and Bottled Water) - Global Forecast to 2028
Markets and Markets: The food safety testing market is projected to reach to reach USD 33.7 billion by 2028, at a CAGR of 8.2% during the forecast period. This report includes a study of the marketing and development strategies, along with the product portfolio of leading companies. These companies include SGS Société Générale De Surveillance SA (Switzerland), Bureau Veritas (France), Intertek Group PLC (UK), Eurofins Scientific (Luxembourg), ALS (Australia), TUV Nord Group (Germany), AsureQuality (New Zealand), Mérieux NutriSciences Corporation (US), Microbac Laboratories, Inc. (Pennsylvania), IFP Institute for Product Quality GmbH (Germany), EMSL Analytical, Inc. (US), Symbio Laboratories (Australia), Hill Laboratories (New Zealand), Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Romer Labs (Austria) among others.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Commercial Vehicle Telematics Software Market by Type (Fleet Management, Safety Management, V2X, Telematics Compliance, Telematics Productivity), Vehicle Type (LCV, MHCV), Propulsion Type (IC Engine, Electric), Sales Channel - Global Forecast to 2028
The commercial vehicle telematics software market size is projected to reach USD 10.3 billion by 2028, reflecting a robust CAGR of 14.3% during the forecast period. Some major players in the commercial vehicle telematics software market include include Verizon Connect (US), Geotab (Canada), Trimble (US), Omnitracs (US), TomTom (Netherlands) along with startups and SMEs such as Motive (US), Nauto (US), Fleetx.io (India), Onfleet (US), and Vontier (US) .
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
The global biomarkers market, valued at USD 58.07 billion in 2024, stood at USD 62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of USD 104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Radiation Detection, Monitoring & Safety Market by Product (Personal Dosimeter; Monitor: Area Process, Environment, Material; Software), Composition (GM Counter, Scintillator), End User (Nuclear Plants, Healthcare, Defense) – Global Forecast to 2031
The radiation detection, monitoring & safety market is expected to grow from USD 3.80 billion in 2026 to USD 5.68 billion by 2031 at a CAGR of 8.4%. Key players in the radiation detection, monitoring & safety market include Fortive (US), Mirion Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Fuji Electric Co., Ltd. (Japan).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers Market, valued at US$13.51 billion in 2024, stood at US$14.73 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$26.40 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Environment, Health, and Safety Market by Offering (Software and Services (Analytics, Project Deployment and Implementation, Audit, Assessment, and Regulatory Compliance, Certification)), Application, Vertical & Region - Global Forecast to 2029
The environment, health, and safety market size is projected to reach USD 11.5 billion by 2029 at a CAGR of 7.6% during the forecast period. The report profiles key players such as VelocityEHS (US), Wolters Kluwer (Netherlands), Intelex Technologies (Canada), Benchmark ESG (US), Cority Software Inc. (Canada), Sphera (US), Intertek (UK), Quentic (Germany), UL Solutions (US), Ideagen (UK), SAP (Germany), IBM (US), Evotix (UK), EcoOnline (Norway), Diligent Corporation (US), ETQ (US), 3E (US), Dakota Software Corporation (US), IsoMetrix (US), Enhesa (US), VisiumKMS (US), SafetyCulture (Australia), TextContext (Canada), ComplianceQuest (US), Pro-Sapien (UK), SHEQX (Australia), CMO Software (UK), Indus Environmental Services (India), Inicia (Japan), ASK-EHS Engineering (India), SHE Group (South Africa), and EHS Brazil (Brazil).
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Genomic Biomarkers Market by Product & Service (Consumable, Software), Type (Safety, Efficacy), Technology (NGS, PCR), Disease (Cancer, Infectious) -Forecast to 2030
The global genomic biomarkers market, valued at US$26.78 billion in 2024, stood at US$29.00 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2024 to 2030, culminating in a forecasted valuation of US$50.31 billion by the end of the period. Genomic biomarkers are measurable features of DNA and RNA used to aid disease diagnosis, characterize disease states, and guide therapeutic decision-making.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
